ThomasTAmatrudaIIIMD

Oncology • Fridley, MN

Physician

Join to view full profile

Dr. Amatruda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Amatruda's full profile

Already have an account?

Office
480 Osborne Rd NE
Ste 220
Fridley, MN 55432
Phone+1 763-786-1620

Fax+1 763-780-3099

Education & Training

California Institute of TechnologyPost-Doctoral Fellowship, Biology, Signal Transduction, 1985 - 1992
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
UCSF Health1978 - 1981
Yale School of MedicineClass of 1978

Certifications & Licensure

MN State Medical License 1992 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2006 Oct 01
Completed
Phase 2
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Completed
Phase 3

Publications & Presentations

PubMed

Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III tria...
Laurie E McLouth, Yue Zheng, Stephanie Smith, F Stephen Hodi, Uma N Rao
Quality of Life Research. 2023-01-01
1 citations
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Phuong L Mai, Austin Miller, Amanda Black, Roni T Falk, John F Boggess
American Journal of Obstetrics and Gynecology. 2022-07-01
41 citations
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma
Robert H.I. Andtbacka, Thomas Amatruda, John Nemunaitis, Jonathan S. Zager, John Walker
Ebiomedicine. 2019-09-01